Clover Health Investments, Corp. logo

Clover Health Investments, Corp. (CLOV)

Market Closed
16 Oct, 08:00 PM
NASDAQ (NGS) NASDAQ (NGS)
$
4. 48
-0.2
-4.2735%
$
2.48B Market Cap
- P/E Ratio
- Div Yield
3.65M Volume
- Eps
$ 4.68
Previous Close
Add Transaction
Day Range
4.46 4.71
Year Range
1.58 5.59
Want to track CLOV and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Clover Health Investments (CLOV) Is Attractively Priced Despite Fast-paced Momentum

Clover Health Investments (CLOV) Is Attractively Priced Despite Fast-paced Momentum

Clover Health Investments (CLOV) made it through our 'Fast-Paced Momentum at a Bargain' screen and could be a great choice for investors looking for stocks that have gained strong momentum recently but are still trading at reasonable prices.

Zacks | 2 years ago
3 Healthcare AI Stocks Positioned for Potential Breakthroughs

3 Healthcare AI Stocks Positioned for Potential Breakthroughs

Markets tanked on Monday because the Japanese central bank raised its interest rate to 0.25%. Interest rates were originally at a benchmark between 0 and 0.1, meaning a minor 15- to 25-basis-point increase had significant consequences for investors who were making margin calls with Yen.

Investorplace | 2 years ago
Clover Health Investments, Corp. (CLOV) Q2 2024 Earnings Call Transcript

Clover Health Investments, Corp. (CLOV) Q2 2024 Earnings Call Transcript

Clover Health Investments, Corp. (NASDAQ:CLOV ) Q2 2024 Earnings Conference Call August 5, 2024 5:00 PM ET Company Participants Ryan Schmidt - IR Andrew Toy - CEO Peter Kuipers - CFO Conference Call Participants Richard Close - Canaccord Genuity Inc. Jason Cassorla - Citigroup Whit Mayo - Leerink Partners Operator Ladies and gentlemen good afternoon, and welcome to the Clover Health Second Quarter 2024 Earnings Conference Call. At this time all participants are in a listen-only mode.

Seekingalpha | 2 years ago
Clover Health Investments, Corp. (CLOV) Q2 Earnings and Revenues Beat Estimates

Clover Health Investments, Corp. (CLOV) Q2 Earnings and Revenues Beat Estimates

Clover Health Investments, Corp. (CLOV) came out with quarterly earnings of $0.01 per share, beating the Zacks Consensus Estimate of a loss of $0.04 per share. This compares to loss of $0.06 per share a year ago.

Zacks | 2 years ago
Clover Health: New Business Model Is A Game Changer

Clover Health: New Business Model Is A Game Changer

Clover Health is making its AI-powered technology platform, Clover Assistant, available for other Medicare Advantage payors and providers under the brand name Counterpart Assistant. The new offering will employ a hybrid SaaS and shared-savings revenue model, with options for full capitation, which will boost its margins. Counterpart Assistant could be highly coveted due to its ability to diagnose chronic diseases early, which helps reduce healthcare costs for insurers.

Seekingalpha | 2 years ago